• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ACRX

ACRX

AcelRx Pharmaceuticals, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD0.86

+0.06 (+7.50%)

Company Profile

CEO

Vincent J. Angotti

IPO Date

2011-02-11

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.78

Prev. Close

$0.80

Day Low

$0.78

Day High

$0.88

52W Low

$0.42

52W High

$2.30

Market Cap

$0.01B

Volume

0.24M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

36.6%

Avg Negative

1.8%

Avg Neutral

61.7%

News Feed

AcelRx Pharmaceuticals: How The Licensing Agreements Could Become A Shot In The Arm

Seeking Alpha·7/27/2021·↑ positive

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ACRX

PRNewsWire·7/26/2021·↑ positive

ACRX Investor Notice: Rosen, Trusted Investor Counsel, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ACRX

Newsfile Corp·7/20/2021·↑ positive

ACRX ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRX

Newsfile Corp·7/17/2021·↑ positive

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action – ACRX

Business Wire·7/16/2021·↑ positive

AcelRx (ACRX) Inks Agreement With Aguettant for Dzuveo in Europe

Zacks Investment Research·7/15/2021·↑ positive

ACRX Stock Increased 23.77%: Why It Happened

Pulse2·7/14/2021·↑ positive

5 Reddit Penny Stocks to Watch That Are Moving Right Now

PennyStocks·7/14/2021·↑ positive

ROSEN, A LEADING LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRX

Newsfile Corp·7/14/2021·↑ positive

AcelRx, Aguettant Ink Licensing Agreements For Dzuveo And Two Prefilled Syringe Products

Benzinga·7/14/2021·↑ positive